Access
To read this story in full you will need to login or make a payment (see right).
Outlook
Nature 449, 180-182 (13 September 2007) | doi:10.1038/449180a; Published online 12 September 2007
Open Innovation Challenges
- More Challenges
- Powered by:
nature jobs
Chief Scientific Manager - Medicinal Chemistry
- Syngene International
- Bangalore, Karnataka 560099 India
Research Fellow
- Beth Israel Deaconess Medical Center
- Beth Israel Deaconess Medical Center, 330 Brookline Avenue, Boston, MA 02215
Neglected Diseases The road to recovery
Carlos M. Morel1, José R. Carvalheiro2, Carmen N. P. Romero3, Eduardo A. Costa4 & Paulo M. Buss5
Abstract
Brazil urgently needs to improve infrastructure for generating pharmaceuticals to alleviate the plight of its poor and marginalized populations, say Carlos M. Morel et al.
Despite Brazil's strength in basic scientific and medical research, a large proportion of the population still suffers from ill health. Diseases such as tuberculosis and leprosy are highly prevalent in poor populations, and about 46,000 people die each year from infectious diseases.
To read this story in full you will need to login or make a payment (see right).
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
NEWS AND VIEWS
Protozoan genomics for drug discoveryNature Biotechnology News and Views (01 Sep 2005)
